PrEP Implementation for Mothers in Antenatal Care
NCT03070600 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 4447
Last updated 2022-07-12
Summary
In a region with 15-20% HIV prevalence, an estimated 20% of HIV-uninfected women could have HIV exposures in pregnancy. In a theoretical scenario of perfect PrEP coverage, all women at risk receive PrEP while no women not at HIV risk receive PrEP (Figure 4). With mandatory PrEP given to all women (similar to the approaches used for malaria prophylaxis), all women at risk would be covered but many women not at risk receive unnecessary PrEP. Our premise is that a targeted PrEP model may be closer to perfect coverage than a universal offer/self-select model. Implementing targeted PrEP through strategies that include facilitation of partner testing with self-tests could add HIV prevention benefit by increasing partner HIV diagnosis and treatment similar to the initiation of PrEP among pregnant women. By implementing these strategies and measuring uptake, use, and HIV incidence, we can inform the best health systems model for PrEP delivery in pregnancy.
Conditions
- HIV Infections
- Pregnancy Related
Interventions
- OTHER
-
Universal PrEP Counseling
Counseling at universal sites, will use a standardized counseling script to state that PrEP is available for women at risk for HIV, explain that HIV prevalence in the region is high, and will note that women with HIV positive partners or who don't know their partner's status may be at risk. Counseling will specify that women may have their own reasons to feel at risk or to want PrEP. Following standardized counseling, women will select PrEP at the same visit or will be allowed to deliberate on the decision and come back at the next visit with a decision. Women will be informed that it is advisable to use PrEP if they know their partner is HIV positive or if they do not know their partner's status and will be encouraged to bring untested partners to clinic if status is unknown.
- OTHER
-
Targeted PrEP Counseling
Following enrollment, the targeted PrEP clinics will provide two inter-related innovations over two ANC visits. In the targeted PrEP clinics, any of the following three criteria can trigger enhanced PrEP counseling. A participant that meets any one of these criteria will receive PrEP counseling during the study visit where the criteria is met: 1. Risk Score \>6 (Risk score includes male partner status known/unknown, syphilis infection, and lifetime number of male partners) or any National AIDS and STI Control Programme (NASCOP) risk factors 2. participant declines partner self-tests regardless of partner HIV status, and/or 3. their partner declines self-testing or tests positive.
Sponsors & Collaborators
-
Kenyatta National Hospital
collaborator OTHER_GOV -
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH - lead OTHER
Principal Investigators
-
Grace John-Stewart, MD, PhD · University of Washington
-
Jared Baeten, MD, PhD · University of Washington
-
John Kinuthia, MBChB, MMed · Kenyatta National Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-15
- Primary Completion
- 2021-01-15
- Completion
- 2021-01-15
- FDA Drug
- Yes
Countries
- Kenya
Study Locations
More Related Trials
-
Supporting Oral and Long-acting PrEP Decision Making Among Pregnant Women in Lilongwe, Malawi
NCT06397690 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and Postpartum
NCT03386578 ·Status: COMPLETED ·Phase: PHASE2
-
STI Testing to Enhance PrEP Use in Pregnancy
NCT06919614 ·Status: RECRUITING ·Phase: PHASE3
-
HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure
NCT03642704 ·Status: COMPLETED ·Phase: PHASE4
-
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
NCT05322629 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
NCT00028145 ·Status: COMPLETED
-
Piloting At-birth Point of Care HIV Testing Strategies in Kenya
NCT03435887 ·Status: COMPLETED ·Phase: NA
-
HIV Testing in Pregnant Women: Evaluating an Opt-Out Testing Strategy
NCT00393302 ·Status: COMPLETED
-
Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
NCT03048669 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women
NCT00006320 ·Status: COMPLETED ·Phase: PHASE1
-
Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women
NCT03227731 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Early ART Initiation Among HIV-positive Pregnant Women in Central Mozambique
NCT02371265 ·Status: COMPLETED ·Phase: NA
-
Optimizing Prevention and Care for Pregnant and Postpartum Adolescent Girls and Young Women With HIV in Tanzania
NCT06605053 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the HITSystem to Improve Early Infant Diagnosis Outcomes in Kenya
NCT02072603 ·Status: COMPLETED ·Phase: NA
-
An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
NCT01836003 ·Status: COMPLETED ·Phase: NA
-
Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1
NCT06435026 ·Status: COMPLETED ·Phase: PHASE2
-
HIV Testing Strategies in the Perinatal Setting
NCT00503308 ·Status: COMPLETED ·Phase: NA
-
Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV
NCT06999928 ·Status: RECRUITING ·Phase: NA
-
Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women
NCT00100867 ·Status: COMPLETED
-
POC HIV Testing and Early DTG Use for Infants
NCT05393193 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Enhanced Virologic Monitoring for Pregnant and Postpartum Women With HIV
NCT05845619 ·Status: COMPLETED ·Phase: NA
-
A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication
NCT01865786 ·Status: COMPLETED
-
An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women
NCT04330989 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants
NCT00000960 ·Status: COMPLETED ·Phase: PHASE3
-
Pre-Exposure Prophylaxis Dosing in Pregnancy to Optimize HIV Prevention (PREP-P)
NCT03834909 ·Status: WITHDRAWN ·Phase: PHASE1